DENAVIR Drug Patent Profile
✉ Email this page to a colleague
When do Denavir patents expire, and when can generic versions of Denavir launch?
Denavir is a drug marketed by Mylan and is included in one NDA.
The generic ingredient in DENAVIR is penciclovir. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the penciclovir profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Denavir
A generic version of DENAVIR was approved as penciclovir by TEVA PHARMS USA on November 9th, 2022.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DENAVIR?
- What are the global sales for DENAVIR?
- What is Average Wholesale Price for DENAVIR?
Summary for DENAVIR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 110 |
Clinical Trials: | 1 |
Patent Applications: | 4,952 |
Drug Prices: | Drug price information for DENAVIR |
What excipients (inactive ingredients) are in DENAVIR? | DENAVIR excipients list |
DailyMed Link: | DENAVIR at DailyMed |
Recent Clinical Trials for DENAVIR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Squarex, LLC | Phase 2 |
Pharmacology for DENAVIR
Drug Class | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor |
Mechanism of Action | DNA Polymerase Inhibitors |
US Patents and Regulatory Information for DENAVIR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan | DENAVIR | penciclovir | CREAM;TOPICAL | 020629-001 | Sep 24, 1996 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DENAVIR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mylan | DENAVIR | penciclovir | CREAM;TOPICAL | 020629-001 | Sep 24, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Mylan | DENAVIR | penciclovir | CREAM;TOPICAL | 020629-001 | Sep 24, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Mylan | DENAVIR | penciclovir | CREAM;TOPICAL | 020629-001 | Sep 24, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Mylan | DENAVIR | penciclovir | CREAM;TOPICAL | 020629-001 | Sep 24, 1996 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DENAVIR
See the table below for patents covering DENAVIR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Austria | 208198 | ⤷ Sign Up | |
China | 1053547 | ⤷ Sign Up | |
Bulgaria | 63815 | ⤷ Sign Up | |
Singapore | 114493 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for DENAVIR
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0296560 | 98C0015 | Belgium | ⤷ Sign Up | PRODUCT NAME: PENCICLOVIR; NAT. REGISTRATION NO/DATE: NL 21 303 19980415; FIRST REGISTRATION: GB - 10592/0078 19960228 |
0141927 | 97C0033 | Belgium | ⤷ Sign Up | PRODUCT NAME: PENCICLOVIR; NAT. REGISTRATION NO/DATE: 981 IS 110 F 7; 19970206; FIRST REGISTRATION: GB 10592/0078 19960228 |
0182024 | SPC/GB94/002 | United Kingdom | ⤷ Sign Up | SPC/GB94/002: 20050910, EXPIRES: 20081209 |
0141927 | SPC/GB96/014 | United Kingdom | ⤷ Sign Up | SPC/GB96/014: 20040810, EXPIRES: 20090809 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |